Intranasal vaccination with a Chimeric Chlamydial Antigen BD584 confers protection against Chlamydia trachomatis genital tract infection
<p>Chlamydia is the most common sexually transmitted infection of bacterial origin, and a broadly protective vaccine is urgently needed given the largely asymptomatic nature of the infection and the severe reproductive sequelae in women with untreated infections. The primary aim of this study...
I tiakina i:
Ngā kaituhi matua: | Steven Liang (Author), James B Mahony (Author) |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
Journal of Vaccines and Immunology - Peertechz Publications,
2020-07-14.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
Immune Pathogenesis of Asymptomatic Chlamydia trachomatis Infections in the Female Genital Tract
mā: Steven S. Witkin
I whakaputaina: (1995) -
Persistent "Silent" Chlamydia trachomatis Female Genital Tract Infections
mā: M. Askienazy-Elbhar, me ētahi atu.
I whakaputaina: (1999) -
Efficacy of an Immune Modulator in Experimental Chlamydia trachomatis Infection of the Female Genital Tract
mā: Joseph M. Lyons, me ētahi atu.
I whakaputaina: (2006) -
Chlamydial Lower Genital Tract Infection and Spontaneous Abortion
mā: J. Sozio, me ētahi atu.
I whakaputaina: (1998) -
Imiquimod Does not Affect Shedding of Viable Chlamydiae in a Murine Model of Chlamydia trachomatis Genital Tract Infection
mā: Kyle H. Ramsey, me ētahi atu.
I whakaputaina: (2003)